These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 2550941)

  • 1. A comparison among antinociceptive bioassays for mu and delta agonists.
    Ayres EA; Lemcke PK; Kramer TH; Toth G; Hruby VJ; Burks TF
    Proc West Pharmacol Soc; 1989; 32():167-71. PubMed ID: 2550941
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of the antinociceptive and antitransit effects of DAGO and PLO17 in mice.
    Shook JE; Burks TF
    Proc West Pharmacol Soc; 1985; 28():115-7. PubMed ID: 2999803
    [No Abstract]   [Full Text] [Related]  

  • 3. Antinociceptive actions of novel delta opioid receptor agonists in the mouse.
    Kramer TH; Toth G; Ayres EA; Hruby VJ; Burks TF
    Prog Clin Biol Res; 1990; 328():473-6. PubMed ID: 2154807
    [No Abstract]   [Full Text] [Related]  

  • 4. RX809055AX in vivo: a long lasting opioid antagonist at mu and delta receptors.
    Lemcke PK; Ayres EA; Kramer TH; Burks TF
    Proc West Pharmacol Soc; 1989; 32():173-5. PubMed ID: 2550942
    [No Abstract]   [Full Text] [Related]  

  • 5. Peptide opioid antagonist separates peripheral and central opioid antitransit effects.
    Shook JE; Pelton JT; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Nov; 243(2):492-500. PubMed ID: 2824748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of antinociception to opioid receptor selective agonists after antisense oligodeoxynucleotide-mediated "knock-down" of opioid receptor in vivo.
    Bilsky EJ; Bernstein RN; Hruby VJ; Rothman RB; Lai J; Porreca F
    J Pharmacol Exp Ther; 1996 Apr; 277(1):491-501. PubMed ID: 8613959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between highly selective mu and delta opioids in vivo at the rat spinal cord.
    Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
    NIDA Res Monogr; 1986; 75():97-100. PubMed ID: 2829017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
    He L; Lee NM
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for delta receptor mediation of [D-Pen2,D-Pen5]-enkephalin (DPDPE) analgesia in mice.
    Heyman JS; Mosberg HI; Porreca F
    NIDA Res Monogr; 1986; 75():442-5. PubMed ID: 2828989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (-)TAN-67, in the mouse spinal cord.
    Tseng LF; Narita M; Mizoguchi H; Kawai K; Mizusuna A; Kamei J; Suzuki T; Nagase H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):600-5. PubMed ID: 9023269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL; Tsai AW; Law PY
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel [D-Pen2, D-Pen5]enkephalin derivatives with increased sigma receptor potency and selectivity: potential tools for opioid pharmacology.
    Burks TF; Kramer TH; Davis P; Toth G; Hruby VJ
    NIDA Res Monogr; 1989; 95():291-2. PubMed ID: 2577035
    [No Abstract]   [Full Text] [Related]  

  • 13. Spinal opioid receptors and adenosine release: neurochemical and behavioral characterization of opioid subtypes.
    Cahill CM; White TD; Sawynok J
    J Pharmacol Exp Ther; 1995 Oct; 275(1):84-93. PubMed ID: 7562600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mu opioid antagonist properties of a cyclic somatostatin octapeptide in vivo: identification of mu receptor-related functions.
    Shook JE; Pelton JT; Lemcke PK; Porreca F; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1987 Jul; 242(1):1-7. PubMed ID: 2886635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociception induced by intrathecal coadministration of selective adenosine receptor and selective opioid receptor agonists in mice.
    De Lander GE; Keil GJ
    J Pharmacol Exp Ther; 1994 Feb; 268(2):943-51. PubMed ID: 8114009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective modulation of morphine antinociception, but not development of tolerance, by delta receptor agonists.
    Jiang Q; Mosberg HI; Porreca F
    Eur J Pharmacol; 1990 Sep; 186(1):137-41. PubMed ID: 2178093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats.
    Sbacchi M; La Regina A; Petrillo P; Tavani A
    NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opioids disrupt Ca2+ homeostasis and induce carbonyl oxyradical production in mouse astrocytes in vitro: transient increases and adaptation to sustained exposure.
    Hauser KF; Harris-White ME; Jackson JA; Opanashuk LA; Carney JM
    Exp Neurol; 1998 May; 151(1):70-6. PubMed ID: 9582255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of mu- and delta-opiate receptors in the realization of the autonomic effects of opioid peptides].
    Martynova ER; Medvedev OS
    Biull Eksp Biol Med; 1986 Jan; 101(1):60-3. PubMed ID: 3002521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo and in vitro investigation of naltrindole, a delta-opioid antagonist.
    Ayres EA; Davis P; Burks TF
    Proc West Pharmacol Soc; 1990; 33():55-63. PubMed ID: 2177196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.